Although there is no evidence suggesting that angiotensin-converting enzyme inhibitors (ACEi) are effective in the treatment of LPG, it is reasonable to use these drugs to retard the progression of renal disease in patients with persistent proteinuria (12). The gene discussed is ACE; the disease is kidney disorder.